Caraco Pharmaceutical (CPD) Granted Tentative FDA Approval for Generic Zyrtec
More News related to CPD
- Caraco Pharmaceutical Laboratories, Ltd. Markets Nicardipine Hydrochloride Injection
- Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Opthalmic Solution
- Caraco Pharmaceutical Labs (CPD) Posts Q3 EPS of $0.17
- Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Second Quarter and First Six Months of Fiscal Year 2010
- Caraco Pharmaceutical Laboratories, Ltd. Closes Asset Purchase Agreement with Forest Laboratories, Inc. to Settle Lexapro(R) (escitalopram oxalate) ANDA Patent Litigation
More News related to FDA
- Cornerstone Therapeutics (CRTX) Receives Warning Letter From FDA
- Pfizer (PFE) Gets Okay for Bipolar Treatment Geodon from U.S. FDA
- Intuitive Surgical (ISRG) Receives Japanese Approval for da Vinci
- Dendreon Corp. (DNDN) Receives U.S. FDA Complete Response for PROVENGE CRPC Treatment
- Boston Scientific (BSX) Receives 510(k) Clearance and CE Mark on WallFlex
Caraco Pharmaceutical Laboratories, Ltd., (Amex: CPD) said the FDA has granted tentative approval for the Company's Abbreviated New Drug Application for Cetirizine Hydrochloride Chewable Tablets, 5 mg and 10 mg. Final approval to market this product is anticipated subsequent to the expiry of patent protection on December 25, 2007.
Related Categories
FDAStocks Mentioned
+0.08Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
